Mizuho Cuts Immunocore (IMCR) Price Target to $34 Amid Revenue Trim
Published on 5/11/2026
AI Summary
Summarized by AI from the source belowMizuho Securities reduced Immunocore's (IMCR) stock price target to $34, reflecting a decrease in anticipated revenue. The analysts' revision indicates a potential impact on investor sentiment towards the company. This adjustment comes as market expectations may adjust in response to updated revenue forecasts. The reduction in price target identifies a cautionary stance regarding Immunocore's financial performance and future prospects.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
